Suppr超能文献

脊髓中与转基因肌萎缩侧索硬化症(ALS)模型小鼠错误折叠突变超氧化物歧化酶-1 结合的蛋白质。

Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic amyotrophic lateral sclerosis (ALS) model mice.

机构信息

Department of Medical Biosciences, Clinical Chemistry, Umeå University, SE-901 85 Umeå, Sweden.

出版信息

J Biol Chem. 2011 Jun 10;286(23):20130-6. doi: 10.1074/jbc.M111.218842. Epub 2011 Apr 14.

Abstract

Mutant superoxide dismutase-1 (SOD1) has an unidentified toxic property that provokes ALS. Several ALS-linked SOD1 mutations cause long C-terminal truncations, which suggests that common cytotoxic SOD1 conformational species should be misfolded and that the C-terminal end cannot be involved. The cytotoxicity may arise from interaction of cellular proteins with misfolded SOD1 species. Here we specifically immunocaptured misfolded SOD1 by the C-terminal end, from extracts of spinal cords from transgenic ALS model mice. Associated proteins were identified with proteomic techniques. Two transgenic models expressing SOD1s with contrasting molecular properties were examined: the stable G93A mutant, which is abundant in the spinal cord with only a tiny subfraction misfolded, and the scarce disordered truncation mutant G127insTGGG. For comparison, proteins in spinal cord extracts with affinity for immobilized apo G93A mutant SOD1 were determined. Two-dimensional gel patterns with a limited number of bound proteins were found, which were similar for the two SOD1 mutants. Apart from neurofilament light, the proteins identified were all chaperones and by far most abundant was Hsc70. The immobilized apo G93A SOD1, which would populate a variety of conformations, was found to bind to a considerable number of additional proteins. A substantial proportion of the misfolded SOD1 in the spinal cord extracts appeared to be chaperone-associated. Still, only about 1% of the Hsc70 appeared to be associated with misfolded SOD1. The results argue against the notion that chaperone depletion is involved in ALS pathogenesis in the transgenic models and in humans carrying SOD1 mutations.

摘要

突变型超氧化物歧化酶-1(SOD1)具有一种未知的毒性,会引发肌萎缩侧索硬化症(ALS)。几种与 ALS 相关的 SOD1 突变导致 C 端的长截短,这表明常见的细胞毒性 SOD1 构象物种应该是错误折叠的,而 C 端不能参与。细胞毒性可能是由于细胞蛋白与错误折叠的 SOD1 物种相互作用引起的。在这里,我们专门通过 C 端免疫捕获来自转基因 ALS 模型小鼠脊髓提取物中的错误折叠的 SOD1。使用蛋白质组学技术鉴定相关蛋白。检查了两种具有不同分子特性的转基因模型:稳定的 G93A 突变体,其在脊髓中含量丰富,只有一小部分错误折叠,而罕见的无序截断突变体 G127insTGGG。作为比较,确定了与固定化 apo G93A 突变 SOD1 具有亲和力的脊髓提取物中的蛋白质。发现具有有限数量结合蛋白的二维凝胶模式,对于两种 SOD1 突变体都是相似的。除了神经丝轻链外,鉴定出的蛋白质都是伴侣蛋白,其中含量最多的是 Hsc70。固定化 apo G93A SOD1 会占据多种构象,被发现可以结合相当数量的其他蛋白质。脊髓提取物中相当一部分错误折叠的 SOD1 似乎与伴侣蛋白相关。尽管如此,只有约 1%的 Hsc70 似乎与错误折叠的 SOD1 相关。这些结果表明,伴侣蛋白耗竭与转基因模型和携带 SOD1 突变的人类中的 ALS 发病机制无关。

相似文献

2
Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice.
J Biol Chem. 2011 Jan 28;286(4):2795-806. doi: 10.1074/jbc.M110.186999. Epub 2010 Nov 10.
6
Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.
Brain. 2004 Jan;127(Pt 1):73-88. doi: 10.1093/brain/awh005. Epub 2003 Oct 8.
7
Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models.
Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14157-62. doi: 10.1073/pnas.0700477104. Epub 2007 Aug 21.
10
Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients.
J Neurochem. 2011 Apr;117(1):91-9. doi: 10.1111/j.1471-4159.2011.07177.x. Epub 2011 Feb 9.

引用本文的文献

1
Using ALS to understand profilin 1's diverse roles in cellular physiology.
Cytoskeleton (Hoboken). 2025 Mar;82(3):111-129. doi: 10.1002/cm.21896. Epub 2024 Jul 26.
6
Molecular and pharmacological chaperones for SOD1.
Biochem Soc Trans. 2020 Aug 28;48(4):1795-1806. doi: 10.1042/BST20200318.
8
TNF receptor-associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation.
J Biol Chem. 2020 Mar 20;295(12):3808-3825. doi: 10.1074/jbc.RA119.011215. Epub 2020 Feb 6.
10
Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD.
Front Neurosci. 2019 Jun 11;13:548. doi: 10.3389/fnins.2019.00548. eCollection 2019.

本文引用的文献

1
Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients.
PLoS One. 2010 Jul 14;5(7):e11552. doi: 10.1371/journal.pone.0011552.
2
Superoxide dismutase-1 and other proteins in inclusions from transgenic amyotrophic lateral sclerosis model mice.
J Neurochem. 2010 Jul;114(2):408-18. doi: 10.1111/j.1471-4159.2010.06753.x. Epub 2010 Apr 19.
3
Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond.
J Cell Biol. 2009 Dec 14;187(6):761-72. doi: 10.1083/jcb.200908164.
4
Arimoclomol: a potential therapy under development for ALS.
Expert Opin Investig Drugs. 2009 Dec;18(12):1907-18. doi: 10.1517/13543780903357486.
5
Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models.
Proteomics Clin Appl. 2008 May 1;2(5):670-684. doi: 10.1002/prca.200780023.
6
Familial amyotrophic lateral sclerosis-linked mutant SOD1 aberrantly interacts with tubulin.
Biochem Biophys Res Commun. 2009 Sep 11;387(1):121-6. doi: 10.1016/j.bbrc.2009.06.138. Epub 2009 Jul 1.
7
Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS.
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7774-9. doi: 10.1073/pnas.0902505106. Epub 2009 Apr 30.
8
Changes in the spinal cord proteome of an amyotrophic lateral sclerosis murine model determined by differential in-gel electrophoresis.
Mol Cell Proteomics. 2009 Jun;8(6):1306-17. doi: 10.1074/mcp.M900046-MCP200. Epub 2009 Apr 8.
9
Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS.
Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1392-7. doi: 10.1073/pnas.0813045106. Epub 2009 Jan 26.
10
Adherent monomer-misfolded SOD1.
PLoS One. 2008;3(10):e3497. doi: 10.1371/journal.pone.0003497. Epub 2008 Oct 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验